The rationale for targeting TGF-β in chronic liver diseases.

The rationale for targeting TGF-β in chronic liver diseases.

Item
http://www.wikidata.org/entity/Q38715538
Targeting Hepatocellular Carcinoma: What did we Discover so Far?NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC.Regenerative pharmacology: recent developments and future perspectives.TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research.The EMT spectrum and therapeutic opportunities.Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study.Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism.CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma.How does the tumor microenvironment play a role in hepatobiliary tumors?Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860

The rationale for targeting TGF-β in chronic liver diseases.

Item
http://www.wikidata.org/entity/Q38715538
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The rationale for targeting TGF-β in chronic liver diseases.
@en
type
label
The rationale for targeting TGF-β in chronic liver diseases.
@en
prefLabel
The rationale for targeting TGF-β in chronic liver diseases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The rationale for targeting TGF-β in chronic liver diseases
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698